Gregory A. Reed
Impact in
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
- Biochemistry top 2%
- Eicosanoids and Hypertension Pharmacology
Papers in
- Biochemistry 13
- Eicosanoids and Hypertension Pharmacology 7
- Sulfur Compounds in Biology 5
- Pharmacology 14
- Pharmacogenetics and Drug Metabolism 14
- Inflammatory mediators and NSAID effects 10
- Antibiotics Pharmacokinetics and Efficacy 5
- Co-authors
- A. M. NorthLawrence J. MarnettThomas E. ElingMatthew S. MayoDebra K. SullivanAryeh HurwitzJames A. CrowellShrikant Anant
- Journals
- Carcinogenesis (7 papers)The FASEB Journal (4 papers)Cancer Epidemiology Biomarkers & Prevention (3 papers)Drug Metabolism Reviews (2 papers)Archives of Biochemistry and Biophysics (2 papers)
- Partner nations
- United StatesBelgiumCanada
In The Last Decade
Gregory A. Reed
60 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 137
- Toxicology 105
- Biochemistry 198
- Pharmacology 200
- Organic Chemistry 484
- Cancer Research 230
Countries citing papers authored by Gregory A. Reed
This map shows the geographic impact of Gregory A. Reed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory A. Reed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory A. Reed more than expected).
Fields of papers citing papers by Gregory A. Reed
This network shows the impact of papers produced by Gregory A. Reed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory A. Reed. The network helps show where Gregory A. Reed may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gregory A. Reed, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 11 | |
| 2 | 2019 | 17 | |
| 3 | 2017 | 108 | |
| 4 | 2016 | 22 | |
| 5 | 2015 | 15 | |
| 6 | 2015 | 52 | |
| 7 | 2014 | 15 | |
| 8 | 2012 | 1 | |
| 9 | 2011 | 4 | |
| 10 | 2011 | 154 | |
| 11 | Weighing In: Rural Iowa Principals’ Perceptions of State-Mandated Teaching Evaluation Standards | 2008 | 1 |
| 12 | Probe drug investigations suggest no pharmacokinetic interactions with ginseng and ginkgo biloba supplements | 2007 | 2 |
| 13 | 2003 | 25 | |
| 14 | 2001 | 8 | |
| 15 | 1994 | 9 | |
| 16 | 1992 | 4 | |
| 17 | 1990 | 7 | |
| 18 | 1990 | 15 | |
| 19 | 1989 | 48 | |
| 20 | 1987 | 12 |
About Gregory A. Reed
Gregory A. Reed is a scholar working on Biochemistry, Pharmacology, Pharmacology, Organic Chemistry and Physiology, having authored 62 papers that have together received 2.0k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (14 papers), Inflammatory mediators and NSAID effects (10 papers), Eicosanoids and Hypertension Pharmacology (7 papers), Genomics, phytochemicals, and oxidative stress (6 papers), Free Radicals and Antioxidants (5 papers), Glutathione Transferases and Polymorphisms (5 papers), Sulfur Compounds in Biology (5 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). The work is most often cited by research in Toxicology (105 citations), Biochemistry (198 citations), Pharmacology (200 citations), Organic Chemistry (484 citations) and Cancer Research (230 citations). Gregory A. Reed has collaborated with scholars based in United States, Belgium and Canada. Frequent co-authors include A. M. North, Lawrence J. Marnett, Thomas E. Eling, Matthew S. Mayo, Debra K. Sullivan, Aryeh Hurwitz, James A. Crowell, Shrikant Anant, H. John Smith and Amitabha Ray. Their work appears in journals such as Carcinogenesis, The FASEB Journal, Cancer Epidemiology Biomarkers & Prevention, Drug Metabolism Reviews and Archives of Biochemistry and Biophysics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.